Adapting to funding and operational hurdles in today’s clinical trials landscape
Against the backdrop of geopolitical tensions and economic measures such as tariffs, which are influencing supply chains across numerous industries,…
Against the backdrop of geopolitical tensions and economic measures such as tariffs, which are influencing supply chains across numerous industries,…
“Japan has the second biggest market for branded drugs and is the third largest market for pharmaceuticals overall,” says Kento…
At the 15th Annual Outsourcing in Clinical Trials (OCT) Europe conference, which took place between 29 and 30 April in…
An analysis of clinical trial registries, including ClinicalTrials.gov and Australian and New Zealand registries, has shown a 20% reduction in…
Against the backdrop of the recent US Food and Drug Administration’s (FDA) staff cuts and administrative realignment, understanding accelerated approval…
Is the clinical trials field doing enough to centre the needs and concerns of patients in research? That was the…
A transformative application of artificial intelligence (AI) in drug development lies in its potential to match the right patient population…
Roche is committed to reach net zero greenhouse gas emissions across Scope 1, 2 and 3 by 2045, with interim…
“It would not be surprising to not see new FDA guidance documents issued for some period of time,” said David…
The aim of the EU Clinical Trials Regulation (CTR) is to harmonise the clinical trial regulation process across 27 countries…